Skip to main content

sepsis Archives

Putting the brakes on sepsis

May. 9, 2018—An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection.

Read more


What’s On My Mind: America’s partnership with its research universities fuels our common future

Feb. 15, 2018—The lasting impact of the historic partnership between the federal government and America's research universities is the topic of this week's column from Chancellor Nicholas S. Zeppos.

Read more


Sepsis trial ranked No. 1 on critical care website

Feb. 15, 2018—A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.

Read more


Career ended by devastating crash, cyclist turns toward curing sepsis

Nov. 2, 2017—Sinead Miller was headed for the Olympic games. Now, thanks to a Department of Defense grant to find new sepsis treatments, the Vanderbilt Ph.D. has developed a device that cleans the blood.

Read more


VU scientists report a way to calm the sepsis “storm”

Jun. 22, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis.

Read more


Pathology of septic shock

Feb. 8, 2017—The signaling molecule IL-15 promotes septic shock, a life-threatening condition involving organ injury caused by infection.

Read more


VUMC researchers seek to crack the code of neonatal sepsis

Jun. 2, 2016—Sepsis, an exaggerated and overwhelming inflammatory response to infection, is a major worldwide killer of babies in the first four weeks of life (neonatal period).

Read more


Immune tolerance in endothelial cells

Jan. 7, 2016—Inducing “tolerance” to bacterial toxins in the endothelial cells that line blood vessels may offer a new approach for preventing the negative consequences of sepsis.

Read more


Antibiotics, fetal vessel defect linked

Oct. 15, 2014—Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis.

Read more


Vanderbilt startup BioNanovations gets accelerated

Aug. 30, 2013—Vanderbilt graduate student Charleson Bell, who is the president of the high tech startup BioNanovations, is participating in a 12-week accelerator program in Silicon Valley specifically designed to encourage underrepresented tech entrepeneurs.

Read more


Acetaminophen: protective in sepsis?

Mar. 28, 2013—In critically ill patients with sepsis, plasma hemoglobin may be a new indicator of disease severity – and a potential target for treatment with acetaminophen.

Read more


Upcoming Events

22 November
10:00 AM

29 November
10:00 AM

06 December
10:00 AM

13 December
10:00 AM

MORE EVENTS »